LPL Financial
ACXP icon

LPL Financial’s Acurx Pharmaceuticals ACXP Stock Holding History

LPL Financial’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,239
Closed -$85.1K – 5276
2024
Q3 		$85.1K Sell
2,239
-448
-17% -$19K ﹤0.01% 4920
2024
Q2 		$121K Buy
2,687
+675
+34% +$29.7K ﹤0.01% 4697
2024
Q1 		$98.6K Buy
2,012
+1,328
+194% +$86.3K ﹤0.01% 4683
2023
Q4 		$52.4K Buy
+684
New +$51.6K ﹤0.01% 4647

Other funds holding ACXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

LPL Financial's ACXP Position: Q4 2024 in Review

LPL Financial sold out of Acurx Pharmaceuticals (ACXP) in Q4 2024, closing a stake of 2,239 shares — an estimated $85.1K sold.

LPL Financial first reported a position in ACXP in Q4 2023 and held it in 4 quarters. The position peaked at $121K in Q2 2024. 26 funds tracked by Wall St. Rank hold ACXP as of Q4 2024.

  • LPL Financial reported no remaining Acurx Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • LPL Financial sold 2,239 Acurx Pharmaceuticals shares in Q4 2024, an estimated $85.1K.
  • LPL Financial first reported a position in Acurx Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • LPL Financial's Acurx Pharmaceuticals position peaked at $121K in Q2 2024.
  • 26 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.